Can you predict what happens when EuroSCORE weds biomarker?

Journal of the American College of Cardiology

Volumn 61, Issue 6, 2013, Pages 682-684

  Lange, Richard A ^a  

^a University of Texas Health Science Center   (United States)

Author keywords

cardiac surgery; EuroSCORE; morbidity; mortality; risk factors

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; GROWTH DIFFERENTIATION FACTOR 15; TROPONIN T;

ACUTE CORONARY SYNDROME; CARDIOMYOPATHY; CLINICAL ASSESSMENT TOOL; CONGESTIVE HEART FAILURE; DISEASE MARKER; DISEASE SEVERITY; EUROPEAN SYSTEM FOR CARDIAC OPERATION RISK EVALUATION; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INFLAMMATION; MORTALITY; NONHUMAN; NOTE; OUTCOME ASSESSMENT; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURGICAL PATIENT; SURGICAL RISK; VALVULAR HEART DISEASE;

EID: 84873403039     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.11.028     Document Type: Editorial

References (23)

1. F. Roques, S.A. Nashef, P. Michel Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients Eur J Cardiothrac Surg 15 1999 816 822 discussion 822-3
2. F. Bhatti, A.D. Grayson, G. Grotte The logistic EuroSCORE in cardiac surgery: how well does it predict operative risk? Heart 92 2006 1817 1820
3. P. Michel, F. Roques, S.A. Nashef Logistic or additive EuroSCORE for high-risk patients? Eur J Cardiothrac Surg 23 2003 684 687 discussion 687
4. S.A. Nashef, F. Roques, L.D. Sharples EuroSCORE II Eur J Cardiothrac Surg 41 2012 734 744 discussion 744-5
5. A.H. van Straten, E.M. Tan, M.A. Hamad, E.J. Martens, A.A. van Zundert Evaluation of the EuroSCORE risk scoring model for patients undergoing coronary artery bypass graft surgery: a word of caution Neth Heart J 18 2010 355 359
6. M.P. Bonaca, D.A. Morrow Defining a role for novel biomarkers in acute coronary syndromes Clin Chem 54 2008 1424 1431
7. D.A. Morrow, J.A. de Lemos Benchmarks for the assessment of novel cardiovascular biomarkers Circulation 115 2007 949 952
8. J.L. Fellahi, Y. Le Manach, G. Daccache, B. Riou, J.L. Gerard, J.L. Hanouz Combination of EuroSCORE and cardiac troponin I improves the prediction of adverse outcome after cardiac surgery Anesthesiology 114 2011 330 339
9. B.H. Cuthbertson, B.L. Croal, D. Rae N-terminal pro-B-type natriuretic peptide levels and early outcome after cardiac surgery: a prospective cohort study Br J Anaesth 103 2009 647 653
10. J. Xu, T.R. Kimball, J.N. Lorenz GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation Circ Res 98 2006 342 350
11. T. Kempf, M. Eden, J. Strelau The transforming growth factor-beta superfamily member growth-differentiation factor-15 protects the heart from ischemia/reperfusion injury Circ Res 98 2006 351 360
12. T. Kempf, A. Zarbock, C. Widera GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice Nat Med 17 2011 581 588
13. S. Taddei, A. Virdis Growth differentiation factor-15 and cardiovascular dysfunction and disease: malefactor or innocent bystander? Eur Heart J 31 2010 1168 1171
14. L.B. Daniels, P. Clopton, G.A. Laughlin, A.S. Maisel, E. Barrett-Connor Growth-differentiation factor-15 is a robust, independent predictor of 11-year mortality risk in community-dwelling older adults: the Rancho Bernardo Study Circulation 123 2011 2101 2110
15. L. Lind, L. Wallentin, T. Kempf Growth-differentiation factor-15 is an independent marker of cardiovascular dysfunction and disease in the elderly: results from the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS) Study Eur Heart J 30 2009 2346 2353
16. K.C. Wollert, T. Kempf, T. Peter Prognostic value of growth- differentiation factor-15 in patients with non-ST-elevation acute coronary syndrome Circulation 115 2007 962 971
17. M.P. Bonaca, D.A. Morrow, E. Braunwald Growth differentiation factor-15 and risk of recurrent events in patients stabilized after acute coronary syndrome: observations from PROVE IT-TIMI 22 Arterioscler Thromb Vasc Biol 31 2011 203 210
18. A. Rohatgi, P. Patel, S.R. Das Association of growth differentiation factor-15 with coronary atherosclerosis and mortality in a young, multiethnic population: observations from the Dallas Heart Study Clin Chem 58 2012 172 182
19. K.M. Eggers, T. Kempf, T. Allhoff, B. Lindahl, L. Wallentin, K.C. Wollert Growth-differentiation factor-15 for early risk stratification in patients with acute chest pain Eur Heart J 29 2008 2327 2335
20. T. Kempf, E. Bjorklund, S. Olofsson Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction Eur Heart J 28 2007 2858 2865
21. K.C. Wollert, T. Kempf, B. Lagerqvist Growth differentiation factor 15 for risk stratification and selection of an invasive treatment strategy in non ST-elevation acute coronary syndrome Circulation 116 2007 1540 1548
22. M. Heringlake, E.I. Charitos, N. Gatz Growth differentiation factor 15: a novel risk marker adjunct to the Euroscore for risk stratification in cardiac surgery patients J Am Coll Cardiol 61 2013 672 681
23. D.A. Brown, S.N. Breit, J. Buring Concentration in plasma of macrophage inhibitory cytokine-1 and risk of cardiovascular events in women: a nested case-control study Lancet 359 2002 2159 2163